Evidence map›Paper›PMID 39688203›Full record

ArticleActa neuropsychiatrica2024

The effect of azelaic acid on AlCl

Saba Vasegh, Hakimeh Saadati, Ali Abedi, Sara Mostafalou

Abstract read
In one paragraph

Article in Acta neuropsychiatrica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. ComparativeFoods (Basel, Switzerland) · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Saba VaseghDepartment of Pharmacology & Toxicology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran.ORCID https://orcid.org/0009-0004-5516-849X
Hakimeh SaadatiDepartment of Physiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.ORCID https://orcid.org/0009-0005-0599-634X
Ali AbediDepartment of Physiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.ORCID https://orcid.org/0000-0002-4289-4941
Sara MostafalouDepartment of Pharmacology & Toxicology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran.ORCID https://orcid.org/0000-0003-2391-7703

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesCognitive function plays a pivotal role in assessing an individual's quality of life. This research aimed to investigate how azelaic acid (AzA), a natural dicarboxylic acid with antioxidant and anti-inflammatory properties, affects aluminium chloride (AlCl

methodsThirty-two male Wistar rats divided into four groups received distilled water, AzA 50 mg/kg, AlCl

resultsAzA significantly affected AlCl

conclusionThese findings disclosed that AzA could improve behavioural and cognitive function and almost limit the oxidative stress and neuroinflammation caused by AlCl

Indexed as

AntioxidantsCognitive DysfunctionDicarboxylic AcidsHippocampusAluminum ChlorideAnimalsBehavior, AnimalBrain-Derived Neurotrophic FactorDisease Models, AnimalMaleMaze LearningOxidative StressRatsRats, WistarAluminum ChlorideAntioxidantsazelaic acidBrain-Derived Neurotrophic FactorDicarboxylic Acidsaluminium chlorideazelaic acidCognitive impairmentneuroinflammationoxidative stress

Identifiers

PMID39688203
PMCPMC13130315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.